Results of Stanford’s Bionic Pancreas Study — A Patient’s Point of View

What is clear is that medically, technologically and economically, we are entering into a new age of diabetes management, one that will slowly alleviate the physical and psychological pressures by utilizing “smart” systems and algorithms that learn about us.

Stanford’s Bionic Pancreas Study — A Patient’s Point of View

The bionic pancreas is a closed loop system that seeks to remove the T1D patient from the equation. Similar to a non-diabetics functioning pancreas, it responds to food consumed so the amount of insulin injected via an infusion set is appropriate for the amount of carbohydrates.

The Human Trial and What it Means for a Cure

Looking for heroism in the forgotten corners of our globe and from those least likely to claim the spotlight, Lisa turns her eye to the stem cell research (regenerative medicine) being done by Viacyte — a biotech company based out of San Diego that is currently undergoing clinical trails, implanting healthy beta cells into a human pancreas.